Notice Number: NOT-FD-15-007
Key Dates
Release Date: June 9, 2015
Issued by
U.S. Food and Drug Administration (FDA)
Purpose
The purpose of this Notice is to change the Funds Available and Award Budget for PAR-15-187.
Now Reads:
Funds Available and Anticipated Number of Awards | The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations, availability of funding and awardee performance. FDA/CDER intends to fund up to $2,000,000, for Fiscal Year 2015 in support of this grant program. Future year amounts will be contingent on availability of Federal funds but it is estimated that FDA/CDER intends to commit up to the following amounts for Fiscal Years (FY) 2016-2019: FY2016: $2,000,000 FY2017: $2,000,000 FY2018: $2,000,000 FY2019: $2,000,000 It is anticipated that up to two (2) awards will be made, not to exceed $1,000,000 in total costs (direct plus indirect), per award, per Fiscal Year. |
Award Budget |
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect): YR 01: $1,000,000 |
Should Read:
Funds Available and Anticipated Number of Awards | The number of awards is contingent upon FDA appropriations and the submission of a sufficient number of meritorious applications. Future year amounts will depend on annual appropriations, availability of funding and awardee performance. FDA/CDER intends to fund up to $6,000,000, for Fiscal Year 2015 in support of this grant program. Future year amounts will be contingent on availability of Federal funds but it is estimated that FDA/CDER intends to commit up to the following amounts for Fiscal Years (FY) 2016-2019: FY2016: $6,000,000 FY2017: $6,000,000 FY2018: $6,000,000 FY2019: $6,000,000 It is anticipated that up to two (2) awards will be made, not to exceed $3,000,000 in total costs (direct plus indirect), per award, per Fiscal Year. |
Award Budget |
Application budgets need to reflect the actual needs of the proposed project and should not exceed the following in total costs (direct and indirect): YR 01: $3,000,000 |
Inquiries
Please direct all inquiries to:
Lisa Ko
U.S. Food and Drug Administration (FDA)
Office of Acquisition and Grants Services
5630 Fishers Lane
Rockville, MD 20857
Telephone: 240-402-7592
Email: [email protected]